OncLive: Dr. Loeb on Determining Beneficial Test Options for Prostate Cancer (published July 2017)
OncLive: Dr. Loeb on Determining Beneficial Test Options for Prostate Cancer (published July 2017)
Las Vegas, Nevada. January 19-21, 2018 Lecture Topic: Genomic markers for prostate cancer, social media Category: Prostate Cancer, Social Media
9/18-9/19 Educational Intervention on Active Surveillance for Prostate Cancer The goal of this project is to create educational modules for physicians on active surveillance for prostate cancer.
Punnen S, Freedland SJ, Polascik TJ, Loeb S, Risk MC, Savage S, Mathur SC, Uchio E, Dong Y, Silberstein JL. ” A Multi-institutional Prospective Trial in the Veterans Affairs Health System confirms the 4Kscore maintains its Predictive value among African American Men.” Journal of Urology 2017, epub Dec 6. PMID: 29223389 Link: https://www.ncbi.nlm.nih.gov/pubmed/29223389
Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J,… Read More
Loeb S. ” Active Surveillance Offers Functional Advantages Without Impacting Survival for Low-risk Prostate Cancer.” European Urology. 2017 Nov 20. PMID: 29169932 Link: https://www.ncbi.nlm.nih.gov/pubmed/29169932
Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J,… Read More
Baltimore, Maryland. November 16, 2017 Lecture Topic: Update on active surveillance and dissemination of knowledge in urology Category: prostate cancer, social media, dissemination and implementation science (D&I)
Loeb S. “Educational intervention in prostate cancer.” BJU International 2017 Nov; 120(5B):E3. PMID: 29105995 Link: https://www.ncbi.nlm.nih.gov/pubmed/29105995
Loeb S, Schlomm T, Stattin P. “Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and Melanoma.” European Urology 2015 epub July. PMID: 26238432. Link: http://www.ncbi.nlm.nih.gov/pubmed/26238432
Loeb S, Montorsi F, Catto JW. “Future-Proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?” European Urology 2015 epub. PMID: 25769986. Link: http://www.ncbi.nlm.nih.gov/pubmed/25769986
Loeb S. “The Age Old Question: Who Benefits From Prostate Cancer Treatment?” British Journal of Urology International 2013; 1134: 4. PMID: 24330057 Link: http://www.ncbi.nlm.nih.gov/pubmed/24330057
Stattin P and Loeb S. ‘To measure is to know. If you cannot measure it, you cannot improve it.’ Statistical Modeling Cannot Compensate for Unmeasured Bias.” European Urology 2013; June epub Link: http://www.ncbi.nlm.nih.gov/pubmed/23830142
Loeb S. “Does Delaying Prostate Cancer Treatment Miss the Window of Curability?” European Urology 2013 epub Apr 8. PMID: 23619388 Link: http://www.ncbi.nlm.nih.gov/pubmed/23619388
Loeb S, Dani H. “Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.” Urol Clin North Am. 2017 Nov; 44(4):517-524. PMID: 29107268 Link: https://www.ncbi.nlm.nih.gov/pubmed/29107268
Loeb S. “Biomarkers for Prostate Biopsy and Risk Stratification of Newly Diagnosed Prostate Cancer Patients.” Urology Practice. 2017 Jul;4(4):315-321. PMID: 29104903 Link: https://www.ncbi.nlm.nih.gov/pubmed/29104903
Tosoian J and Loeb S. “Radical Retropubic Prostatectomy: Comparison of the Open and Robotic Approaches for Treatment of Prostate Cancer.” Reviews in Urology 2012; 14: 1-8. PMID: 23172996. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502048/
Loeb S. “Prediction of Outcomes After Radical Prostatectomy in Patients Diagnosed with Prostate Cancer of Biopsy Gleason Score ≥8 Via Contemporary Multi (≥12)-Core Prostate Biopsy.” BJU International July 2011; 108: 222. PMID: 21718432. Link: http://www.ncbi.nlm.nih.gov/pubmed/21718432
Loeb S, Ross AE. “Genomic testing for localized prostate cancer: where do we go from here?” Current Opinion in Urology. 2017 Jun 28 epub. PMID: 28661898 Link: https://www.ncbi.nlm.nih.gov/pubmed/28661898
Schaeffer EM, Loeb S, and Walsh PC. “The Case for Open Radical Prostatectomy.” Urological Clinics of North America 2010; 37: 49. Link: http://www.ncbi.nlm.nih.gov/pubmed/20152519
Loeb S and Partin AW. “Open versus minimally invasive radical prostatectomy.” Reviews in Urology, Winter 2010; 12: 20. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859144/
Loeb S, Partin AW, and Schaeffer EM. “Complications of Pelvic Lymphadenectomy: Do the Risks Outweigh the Benefits?” Reviews in Urology, Winter 2010; 12: 20. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859138/
Loeb S, Schaeffer EM, and Epstein JI. “The Vanishing Prostate Cancer Phenomenon.” Urology, January 2010 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/20079526
Loeb S and Schaeffer EM. “Optimal Therapy in Localized Prostate Cancer: An Unfolding Story.’” Oncology (Williston Park), September 2009; 23: 843. Link: http://www.ncbi.nlm.nih.gov/pubmed/19839426
Loeb S and Schaeffer EM. “Does Primary Androgen-Deprivation Therapy Improve Survival for Localized Prostate Cancer?” Aging Health 2008; 4: 451. Link: http://www.futuremedicine.com/doi/full/10.2217/1745509X.4.5.451
Loeb S and Catalona WJ. “Open Radical Retropubic Prostatectomy.” Urologic Oncology: Seminars and Original Investigations 2007; 25: 494. Link: http://www.ncbi.nlm.nih.gov/pubmed/18047959
Loeb S and Catalona WJ. “Counterpoint: the case for active treatment.” Journal of the National Comprehensive Cancer Network, August 2007; 5: 699. Link: http://www.ncbi.nlm.nih.gov/pubmed/17692174
Loeb S and Catalona WJ. “Early versus delayed intervention for prostate cancer: the case for early intervention.” Nature Clinical Practice Urology, July 2007; 4: 348. Link: http://www.ncbi.nlm.nih.gov/pubmed/17563779
Lynch J and Loeb S. “The Role of HIFU in Prostate Cancer.” Current Oncology Reports, May 2007; 9: 22. Link: http://www.ncbi.nlm.nih.gov/pubmed/17430694
Loeb S and Nadler RB. “Management of the Complications of External Beam Radiotherapy and Brachytherapy.” Current Urology Reports, May 2006; 7: 200. Link: http://www.ncbi.nlm.nih.gov/pubmed/16630523
Capetown, South Africa. November 8-12, 2016 Lecture topic: Social media in urology Category: Social Media
London, England. 2017 Lecture topic: Social Media Category: Social Media
Lisbon, Portugal. June 28-30, 2017 Lecture topics: Screening for prostate cancer: where do we stand? Category: Prostate Cancer
Hobart, Australia. April 8, 2017 Lecture topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Melbourne, Australia. April 7, 2017 Topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Sydney, Australia. April 5-6, 2017 Topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Adelaide, Australia. April 4, 2017 Topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Brisbane, Australia. April 3, 2017 Topic: Markers and Prostate Cancer Screening Category: Prostate Cancer
Hamburgo, Germany. June 23-24, 2017 Lecture Topic: Clinical Use of Markers in Localized Prostate Cancer Category: Prostate Cancer